Your browser doesn't support javascript.
loading
Efficacy and safety of angiogenesis inhibitors plus immune checkpoint inhibitors in advanced soft tissue sarcoma: a real-world, single-center study.
Liu, Zengjun; Xu, Jing; Liu, Mengyao; Hu, Wenyu; Xu, Ni; Zhu, Dongyuan.
Afiliación
  • Liu Z; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Xu J; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Liu M; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Hu W; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Xu N; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China.
  • Zhu D; Rare Tumors Department, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, 440 Jiyan Road, Jinan, 250117, Shandong, China. 405683898@qq.com.
Sci Rep ; 13(1): 3385, 2023 02 28.
Article en En | MEDLINE | ID: mdl-36854710

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos / Inhibidores de la Angiogénesis / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sarcoma / Neoplasias de los Tejidos Blandos / Inhibidores de la Angiogénesis / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Sci Rep Año: 2023 Tipo del documento: Article País de afiliación: China